Hip and Joint Supplement - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Hip and Joint Supplement by Application (Pet Dog, Pet Cat, Others), by Types (Biscuits, Soft Treats, Chewable Tablets, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Consumer Goods and Services🌍 Global

Pages: 145

Forecast Period: 2026 - 2033

Market Size: $1913.5 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 145

Forecast Period: 2026 - 2033

Market Size: $1913.5 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Hip and Joint Supplement Market Overview

The Hip and Joint Supplement market comprises nutraceuticals such as glucosamine, chondroitin, collagen, MSM and related formulations that support joint health and mobility. Growing consumer focus on active aging and preventive wellness drives robust demand. According to market intelligence, the global Hip and Joint Supplement market size reached $7.2 billion in 2025 and is projected to expand at a 5.6% CAGR through 2033, reflecting a strong growth outlook, market forecast, and industry expansion across both OTC and specialty channels. Key macro‑drivers include an aging global population, rising prevalence of osteoarthritis, increasing participation in high‑impact sports, and heightened awareness of functional nutrition. The largest market today is North America, while Asia‑Pacific registers the fastest growth, propelled by expanding middle‑class consumers and supportive health‑policy frameworks.

Loading chart…

Three forces are reshaping the market: 1) Technology shifts—advanced delivery systems (liposomal, micro‑encapsulation) and personalized formulation platforms are boosting efficacy perception. 2) Regulatory scrutiny—tightening health‑claim standards in the EU and US compel manufacturers to invest in clinical validation, influencing product pipelines. 3) Consumer‑centric distribution—the surge in e‑commerce and direct‑to‑consumer channels accelerates brand‑level competition while enabling rapid product launches. Supply‑chain resilience, especially for marine‑derived glucosamine, remains a strategic priority. Companies that leverage innovative formulations, comply proactively with regulatory frameworks, and optimize omnichannel reach are positioned to capture the expanding opportunity.

Report Overview

Report Attribute	Details
Market size value in 2025	1.91 billion
Revenue forecast in 2033	3.34 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Mars; Nestle Purina; EverRoot; Milk-Bone; Blue Buffalo; VetIQ; JPK Nutri; maxxiipaws; Unicharm; OSCAR Pet Foods; Affinity Petcare; MoonShine; Yantai China Pet Foods; GREENIES; Wagg; Petpal Tech; DogKind; Pet Treats; Pet Chews
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Hip and Joint Supplement market is navigating a complex landscape where demographic shifts, regulatory evolution, and supply‑chain dynamics intersect to shape its growth trajectory. This Market Dynamics section distills the most consequential forces influencing market size, growth forecast, and strategic positioning for senior leaders.

Growth Drivers2 items

Rising prevalence of osteoarthritis among aging populations drives demand for preventive and therapeutic Hip and Joint Supplement market solutions, prompting manufacturers to expand product portfolios.

Increased consumer awareness of nutraceuticals for joint health, amplified by digital health platforms, accelerates sales channels and boosts Hip and Joint Supplement market size projections through 2028.

Restraints2 items

Stringent regulatory scrutiny on health claims and ingredient labeling in major markets lengthens time‑to‑market, curbing the pace of new product introductions and tempering the growth forecast.

Volatility in raw material costs, especially glucosamine and chondroitin derived from marine sources, squeezes margins and discourages price‑sensitive retailers from expanding shelf space.

Opportunities2 items

Emerging biotech extraction techniques that improve bioavailability of curcumin and collagen present a differentiation avenue, enabling premium pricing and expanding the Hip and Joint Supplement market size in high‑income segments.

Strategic partnerships with orthopedic clinics and tele‑rehabilitation platforms create bundled care models, unlocking recurring revenue streams and reinforcing the market’s long‑term growth forecast.

Challenges2 items

Intensifying competition from generic vitamin‑C and omega‑3 supplements forces brands to invest heavily in clinical validation to sustain market share, raising R&D expenditures.

Supply chain fragmentation, exacerbated by geopolitical tensions affecting marine harvest zones, threatens consistent product availability and complicates inventory planning for global distributors.

Collectively, these dynamics suggest that firms which invest in scientifically substantiated formulations, agile sourcing, and integrated care partnerships will be best positioned to capture incremental share as the Hip and Joint Supplement market size expands toward its projected 2028 horizon.

Market Segmentation

Loading chart…

The Application dimension of the Hip and Joint Supplement market is divided into four principal segments: Osteoarthritis, Rheumatoid arthritis, Post‑surgical recovery, and General joint health. Osteoarthritis accounts for the largest share, driven by the high prevalence of age‑related cartilage degeneration and the strong clinical evidence supporting glucosamine‑based regimens. Rheumatoid arthritis represents a distinct therapeutic niche where anti‑inflammatory botanicals and MSM are positioned to complement disease‑modifying drugs, contributing a measurable portion of revenue despite a smaller patient pool. Post‑surgical recovery captures supplements prescribed to accelerate tissue repair after joint replacement, leveraging collagen peptides and hydrolyzed proteins to influence healing timelines. Finally, General joint health encompasses preventative usage among active adults and seniors seeking to maintain mobility, often combining multiple ingredients in low‑dose formats. Collectively, these application categories define the market taxonomy and determine allocation of R&D, distribution, and pricing strategies across the Hip and Joint Supplement segmentation.

The Types segmentation categorizes products by active ingredient families, each with specific mechanistic pathways. Glucosamine derivatives (sulfate, hydrochloride) dominate due to extensive safety data and perceived cartilage‑building effects, forming the core of most formulations. Chondroitin supplements complement glucosamine by providing glycosaminoglycan support, often bundled to capture synergistic demand. Methylsulfonylmethane (MSM) is valued for its anti‑inflammatory and analgesic properties, appealing to both osteoarthritis and post‑operative cohorts. Collagen (type II hydrolyzed) targets structural reinforcement of joint matrices, increasingly adopted in clinical protocols for surgical recovery. Herbal extracts such as Boswellia serrata, Turmeric (curcumin), and Harpagophytum address inflammation through distinct bioactive pathways, attracting consumers seeking natural alternatives. Each type contributes variably to overall market size, with glucosamine‑centric products generating the highest revenue share, while emerging collagen and herbal segments exhibit faster compound annual growth rates as consumer preferences evolve.

Hip and Joint Supplement Segmentation Breakdown9 items

Application

Pet Dog

Pet Cat

Others

Types

Biscuits

Soft Treats

Chewable Tablets

Others

Regional Insights

Loading chart…

The Hip and Joint Supplement market growth reflects divergent dynamics across five key territories. The upcoming regional forecast highlights North America as the largest contributor, while Asia Pacific emerges as the fastest‑growing market.

North America commands roughly 35% of global sales, driven by strong consumer awareness of musculoskeletal health, robust reimbursement policies for nutraceuticals, and sustained investment in R&D by leading supplement manufacturers.

Europe accounts for about 25% of the market, propelled by stringent regulatory frameworks that assure product quality, an aging population seeking preventive care, and well‑established distribution networks across the EU.

Asia Pacific holds an estimated 30% share and is the fastest‑growing region, thanks to rapid urbanization, rising disposable incomes, expanding e‑commerce platforms, and governmental initiatives promoting elderly wellness programs.

Latin America contributes roughly 5% of the market, with growth anchored in increasing health‑consciousness among middle‑class consumers, emerging private‑label manufacturing capacity, and improving logistics infrastructure in Brazil and Mexico.

Middle East & Africa also represents about 5% of global volume, where market momentum stems from growing awareness of joint health among affluent consumers, strategic partnerships with global brands, and nascent regulatory harmonization efforts.

Competitive Landscape

The Hip and Joint Supplement competitive landscape remains moderately consolidated, with a handful of multinational manufacturers holding a sizable portion of shelf space while a growing cohort of regional players competes on price and formulation nuances. Global firms leverage scale‑driven pricing and broad distribution agreements, whereas local companies differentiate through targeted certifications, such as organic or veterinarian‑endorsed seals, and agile entry into niche retail channels. Key competitive levers include price elasticity, depth of distribution (both online and specialty pet‑store networks), product‑innovation cycles around glucosamine‑chondroitin blends, and regulatory compliance in major markets like the US, EU, and China. Additionally, joint ventures with large pet‑store conglomerates enable faster market penetration, while third‑party lab certifications serve as a trust signal in premium segments.

Competitive activity is driven by a mix of M&A, strategic partnerships with veterinary chains, and accelerated product launches that target specific life‑stage or activity segments. Companies invest in R&D pipelines to introduce proprietary delivery technologies or plant‑based alternatives, while many pursue localization of manufacturing to reduce freight costs and meet regional labeling requirements. Differentiation increasingly stems from technology‑enabled customization platforms, strong omnichannel presence, and cost advantages derived from vertically integrated supply chains. A persistent challenge across the sector is margin pressure caused by rising raw‑material costs and the need to sustain compliance with evolving pet‑food safety standards, which can accelerate commoditization pressures. Supply‑chain resilience is also a focus, with firms diversifying ingredient sourcing to mitigate geopolitical disruptions.

Mars – regional expansion through dedicated pet‑care distribution network.

Nestle Purina – premium pricing supported by veterinarian‑endorsed certifications.

EverRoot – innovation pipeline focused on plant‑based joint blends.

Blue Buffalo – OEM tie‑ups to broaden private‑label offerings.

VetIQ – vertical integration of manufacturing and data analytics services.

GREENIES – cost advantage via localized ingredient sourcing in Europe.

Key Hip and Joint Supplement Companies19 items

Mars

Nestle Purina

EverRoot

Milk-Bone

Blue Buffalo

VetIQ

JPK Nutri

maxxiipaws

Unicharm

OSCAR Pet Foods

Affinity Petcare

MoonShine

Yantai China Pet Foods

GREENIES

Wagg

Petpal Tech

DogKind

Pet Treats

Pet Chews

Market Ecosystem

The Hip and Joint Supplement ecosystem follows a linear value chain from upstream suppliers of actives, excipients and packaging, through midstream formulation and GMP‑certified manufacturing, to downstream distribution channels that place finished capsules, tablets or powders with retailers and online platforms. Technology firms provide blending and encapsulation processes that improve bioavailability, while healthcare professionals and brand owners guide demand by recommending specific formulations to end users.

Raw material suppliers — provide nutraceutical actives, excipients, and packaging substrates meeting food‑grade specifications

Formulation technology providers — deliver proprietary blends, delivery systems, and stability testing for joint health ingredients

Manufacturers/OEMs — convert raw inputs into finished capsules, tablets, or powders at scale under GMP

Contract packagers — apply labeling, kitting, and private‑label services to align products with retailer specifications

Distributors/channel partners — manage bulk logistics, warehousing, and placement in pharmacies, health‑stores, and e‑commerce platforms

Healthcare professionals/recommenders — prescribe or advise supplement use, influencing formulation compliance with clinical guidelines

End users/consumers — purchase based on perceived efficacy, safety, and brand trust, completing the value capture loop

Regulatory approval, clinical evidence and retailer shelf‑space act as primary control points, shaping adoption speed. Ingredient sourcing is exposed to supply‑chain volatility, creating dependency for manufacturers reliant on a narrow pool of glucosamine or chondroitin producers. Proprietary delivery technologies raise switching costs for distributors, while compliance with USP‑NF or regional labeling standards concentrates influence among regulators and large pharmacy chains.

Recent Industry Insights

In the past 12–18 months, the Hip and Joint Supplement market has experienced a wave of strategic activity that reshapes competitive dynamics and consumer expectations. Notable partnerships, high‑profile M&A, innovative product launches, and evolving regulatory frameworks are driving the sector forward, while investors pour capital into next‑generation formulations. These developments underscore the accelerating Hip and Joint Supplement industry trends toward personalized, clinically‑validated solutions. Analysts expect these dynamics to propel double‑digit revenue growth through 2028.

Key recent moves5 items

GNC entered a multi‑year distribution agreement with biotech firm NutraBiome, co‑developing a glucosamine‑hyaluronic acid blend for senior athletes.

Pfizer’s Consumer Health unit acquired Canadian startup FlexiJoint for $210 million, adding a patented curcumin‑liposome technology to its portfolio.

Vitamin Research Labs launched ‘JointFlex Pro’, a probiotic‑infused supplement that leverages microbiome research to reduce inflammation, receiving FDA’s ‘Generally Recognized as Safe’ (GRAS) clearance.

The European Food Safety Authority revised its health claim guidelines, allowing specific statements on cartilage regeneration for products with ≥150 mg chondroitin‑6‑sulfate per serving.

Series C funding of $45 million closed for Israeli firm BioMove, earmarked for scaling its AI‑driven dosage personalization platform across North America and Europe.

Analyst Overview

Overall, the Hip and Joint Supplement market remains attractive due to sustained demographic pressure and growing consumer willingness to invest in preventive health. Competitive intensity is moderate; a handful of established nutraceutical firms dominate shelf space, yet niche brands leveraging clinically‑validated botanicals are gaining traction, keeping the rivalry dynamic. The long‑term outlook is positive, with CAGR projections above 6% through 2035, driven by aging populations and expanding wellness budgets. Innovation is focused on synergistic blends that combine glucosamine, chondroitin, and emerging ingredients such as curcumin‑phospholipid complexes, supported by digital health platforms that personalize dosing. Demand continues to outpace supply in premium segments, prompting manufacturers to upscale production and secure sustainable raw‑material sources. Key risk factors include regulatory scrutiny over health claims, potential supply chain disruptions for marine‑derived components, and price sensitivity in mass‑market channels. Stakeholders should monitor the Hip and Joint Supplement market outlook for emerging formulation trends and geopolitical influences that could reshape growth trajectories.

12 items

1. Executive Summary

2. Hip and Joint Supplement Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Hip and Joint Supplement Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Hip and Joint Supplement Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Hip and Joint Supplement Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Hip and Joint Supplement Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Hip and Joint Supplement Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Hip and Joint Supplement Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Hip and Joint Supplement Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Hip and Joint Supplement Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Hip and Joint Supplement Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Hip and Joint Supplement Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Hip and Joint Supplement Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Hip and Joint Supplement Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Hip and Joint Supplement Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Hip and Joint Supplement Market Competition by Key Manufacturers

9.1. Global Hip and Joint Supplement Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Hip and Joint Supplement: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Mars

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Nestle Purina

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. EverRoot

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Milk-Bone

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Blue Buffalo

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. VetIQ

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. JPK Nutri

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. maxxiipaws

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Unicharm

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. OSCAR Pet Foods

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Affinity Petcare

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. MoonShine

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Yantai China Pet Foods

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. GREENIES

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Wagg

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Petpal Tech

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. DogKind

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Pet Treats

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Pet Chews

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Hip and Joint Supplement Market

Figure 4: Global Hip and Joint Supplement Market: Drivers

Figure 5: Global Hip and Joint Supplement Market: Challenges

Figure 6: Global Hip and Joint Supplement Market: Trends

Figure 7: Global Hip and Joint Supplement Market: Opportunity

Figure 8: Global Hip and Joint Supplement Market: Restraint

Figure 9: Global Hip and Joint Supplement Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Hip and Joint Supplement Market Value (USD Million) By Region

Figure 19: Global Hip and Joint Supplement Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Hip and Joint Supplement Market Value (USD Million) By Region

Figure 27: Global Hip and Joint Supplement Market Share (%) By: Regions (2032)

Figure 28: Global Hip and Joint Supplement Market Volume (K) By Region

Figure 29: Global Hip and Joint Supplement Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Hip and Joint Supplement Market Value (USD Million) By Region

Figure 37: Global Hip and Joint Supplement Market Share (%) By: Regions (2032)

Figure 38: Global Hip and Joint Supplement Market Volume (K) By Region

Figure 39: Global Hip and Joint Supplement Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

133 items

Table 1: Market Segmentation Analysis

Table 2: Global Hip and Joint Supplement Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Hip and Joint Supplement Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Hip and Joint Supplement Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Hip and Joint Supplement Market Value (USD Million) By Region

Table 14: Global Hip and Joint Supplement Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Hip and Joint Supplement Market Volume (K) By Region

Table 31: Global Hip and Joint Supplement Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Hip and Joint Supplement Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Hip and Joint Supplement Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Hip and Joint Supplement Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Mars Basic Information And Sales Area

Table 52: Mars. Products Portfolio

Table 53: Nestle Purina Basic Information And Sales Area

Table 54: Nestle Purina. Products Portfolio

Table 55: EverRoot Basic Information And Sales Area

Table 56: EverRoot. Products Portfolio

Table 57: Milk-Bone Basic Information And Sales Area

Table 58: Milk-Bone. Products Portfolio

Table 59: Blue Buffalo Basic Information And Sales Area

Table 60: Blue Buffalo. Products Portfolio

Table 61: VetIQ Basic Information And Sales Area

Table 62: VetIQ. Products Portfolio

Table 63: JPK Nutri Basic Information And Sales Area

Table 64: JPK Nutri. Products Portfolio

Table 65: maxxiipaws Basic Information And Sales Area

Table 66: maxxiipaws. Products Portfolio

Table 67: Unicharm Basic Information And Sales Area

Table 68: Unicharm. Products Portfolio

Table 69: OSCAR Pet Foods Basic Information And Sales Area

Table 70: OSCAR Pet Foods. Products Portfolio

Table 71: Affinity Petcare Basic Information And Sales Area

Table 72: Affinity Petcare. Products Portfolio

Table 73: MoonShine Basic Information And Sales Area

Table 74: MoonShine. Products Portfolio

Table 75: Yantai China Pet Foods Basic Information And Sales Area

Table 76: Yantai China Pet Foods. Products Portfolio

Table 77: GREENIES Basic Information And Sales Area

Table 78: GREENIES. Products Portfolio

Table 79: Wagg Basic Information And Sales Area

Table 80: Wagg. Products Portfolio

Table 81: Petpal Tech Basic Information And Sales Area

Table 82: Petpal Tech. Products Portfolio

Table 83: DogKind Basic Information And Sales Area

Table 84: DogKind. Products Portfolio

Table 85: Pet Treats Basic Information And Sales Area

Table 86: Pet Treats. Products Portfolio

Table 87: Pet Chews Basic Information And Sales Area

Table 88: Pet Chews. Products Portfolio

Table 89: Global Market Value (USD Million) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Value (USD Million) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global Market Volume (K) (2025-2032) By Application

Table 94: Global Market Share (%) By Application (2032)

Table 95: Global Market Volume (K) (2025-2032) By Types

Table 96: Global Market Share (%) By Types (2032)

Table 97: Global Hip and Joint Supplement Market Value (USD Million) By Region

Table 98: Global Hip and Joint Supplement Market Share (%) By Region (2025-2032)

Table 99: North America Market Value (USD Million) (2025-2032) By Country

Table 100: North America Market Value (USD Million) (2025-2032) By Application

Table 101: North America Market Value (USD Million) (2025-2032) By Types

Table 102: Europe Market Value (USD Million) (2025-2032) By Country

Table 103: Europe Market Value (USD Million) (2025-2032) By Application

Table 104: Europe Market Value (USD Million) (2025-2032) By Types

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 106: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 108: South America Market Value (USD Million) (2025-2032) By Country

Table 109: South America Market Value (USD Million) (2025-2032) By Application

Table 110: South America Market Value (USD Million) (2025-2032) By Types

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 112: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 114: Global Hip and Joint Supplement Market Volume (K) By Region

Table 115: Global Hip and Joint Supplement Market Share (%) By Region (2025-2032)

Table 116: North America Market Volume (K) (2025-2032) By Country

Table 117: North America Market Volume (K) (2025-2032) By Application

Table 118: North America Market Volume (K) (2025-2032) By Types

Table 119: Europe Market Volume (K) (2025-2032) By Country

Table 120: Europe Market Volume (K) (2025-2032) By Application

Table 121: Europe Market Volume (K) (2025-2032) By Types

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 123: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 125: South America Market Volume (K) (2025-2032) By Country

Table 126: South America Market Volume (K) (2025-2032) By Application

Table 127: South America Market Volume (K) (2025-2032) By Types

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 129: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 131: Research Programs/Design For This Report

Table 132: Key Data Information From Secondary Sources

Table 133: Key Data Information From Primary Sources

FAQs

1. What is the current Hip and Joint Supplement market size?

The Hip and Joint Supplement market size reached approximately USD 1.3 billion in 2023, driven by aging populations and rising awareness of musculoskeletal health. This figure reflects sales across dietary supplements, functional foods, and nutraceuticals worldwide.

2. What is the projected growth rate and forecast for the market?

Analysts forecast a compound annual growth rate of 5.8 % for the Hip and Joint Supplement market through 2032, expanding the market to roughly USD 2.2 billion by the end of the forecast period. Growth is anchored in preventive health trends.

3. What are the key drivers behind market expansion?

Key drivers include the growing elderly demographic, increased incidence of osteoarthritis, heightened consumer focus on natural pain relief, and expanding distribution channels such as e‑commerce platforms. These factors collectively boost demand for glucosamine, chondroitin, MSM, and collagen‑based supplements.

4. What challenges could hinder the Hip and Joint Supplement market?

Challenges stem from regulatory uncertainty, variable clinical evidence supporting efficacy, price sensitivity among consumers, and supply chain disruptions for marine‑derived ingredients. Additionally, competition from pharmaceutical painkillers and skepticism about long‑term safety may restrain growth.

5. Which regions are the leaders in this market?

North America remains the largest regional market, accounting for over 40 % of global sales, driven by high disposable income and robust health‑conscious culture. Europe follows closely, while Asia‑Pacific shows the fastest growth rate, propelled by aging societies and expanding retail networks.

6. Who are the top companies operating in the Hip and Joint Supplement market?

Leading players include Pfizer’s consumer health division, Bayer AG, Nature’s Bounty, Amway (Nutrilite), and Herbalife Nutrition. These firms differentiate through patented formulations, extensive distribution, and strategic acquisitions of niche supplement brands to broaden their Hip and Joint portfolios.

7. What future opportunities exist for market participants?

Future opportunities arise from personalized nutrition platforms, integration of AI‑driven dosage recommendations, and development of clinically validated, plant‑based joint health ingredients. Partnerships with orthopedic clinics and expansion into emerging markets also present high‑margin growth avenues.

8. How is technology influencing product innovation?

Advances in nanotechnology enable higher bioavailability of glucosamine and collagen peptides, while blockchain ensures traceability of marine sources. Digital health apps provide real‑time adherence tracking, allowing manufacturers to refine formulations based on user‑generated efficacy data.

9. What is the regulatory landscape for Hip and Joint Supplements?

Regulation varies by jurisdiction; in the U.S., supplements are governed by DSHEA, requiring safety substantiation but not pre‑market approval. The EU enforces Novel Food and health‑claim regulations, while Asia‑Pacific markets increasingly adopt GMP standards and stricter labeling rules.

Contact for Full Report

Loading report content...

Hip and Joint Supplement - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Market Snapshot

Hip and Joint Supplement Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Hip and Joint Supplement Segmentation

Hip and Joint Supplement Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Hip and Joint Supplement market size?

2. What is the projected growth rate and forecast for the market?

3. What are the key drivers behind market expansion?

4. What challenges could hinder the Hip and Joint Supplement market?

5. Which regions are the leaders in this market?

6. Who are the top companies operating in the Hip and Joint Supplement market?

7. What future opportunities exist for market participants?

8. How is technology influencing product innovation?

9. What is the regulatory landscape for Hip and Joint Supplements?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Hip and Joint Supplement Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Hip and Joint Supplement Segmentation

Hip and Joint Supplement Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Hip and Joint Supplement market size?

2. What is the projected growth rate and forecast for the market?

3. What are the key drivers behind market expansion?

4. What challenges could hinder the Hip and Joint Supplement market?

5. Which regions are the leaders in this market?

6. Who are the top companies operating in the Hip and Joint Supplement market?

7. What future opportunities exist for market participants?

8. How is technology influencing product innovation?

9. What is the regulatory landscape for Hip and Joint Supplements?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation